SKK
ROSG

Shepherd Kaplan Krochuk’s Rosetta Genomics Ltd. ROSG Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,431
Closed -$66K – 485
2014
Q4 		$66K Sell
2,431
-1,152
-32% -$37.4K 0.01% 433
2014
Q3 		$151K Hold
3,583
– – 0.02% 461
2014
Q2 		$185K Sell
3,583
-375
-9% -$18.6K 0.02% 452
2014
Q1 		$237K Buy
+3,958
New +$204K 0.03% 408

Other funds holding ROSG

HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Shepherd Kaplan Krochuk's ROSG Position: Q1 2015 in Review

Shepherd Kaplan Krochuk sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2015, closing a stake of 2,431 shares — an estimated $66K sold.

Shepherd Kaplan Krochuk first reported a position in ROSG in Q1 2014 and held it in 4 quarters. The position peaked at $237K in Q1 2014. 12 funds tracked by Wall St. Rank hold ROSG as of Q1 2015.

  • Shepherd Kaplan Krochuk reported no remaining Rosetta Genomics Ltd. position as of Q1 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 2,431 Rosetta Genomics Ltd. shares in Q1 2015, an estimated $66K.
  • Shepherd Kaplan Krochuk first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 4 quarters.
  • Shepherd Kaplan Krochuk's Rosetta Genomics Ltd. position peaked at $237K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2015, filed 15 May 2015.